中国麻风皮肤病杂志 ›› 2021, Vol. 37 ›› Issue (8): 525-527.doi: 10.12144/zgmfskin202108525

• 病例报告 • 上一篇    下一篇

重组II型肿瘤坏死因子受体抗体融合蛋白联合糖皮质激素成功治疗重症多形红斑型药疹一例

路文华,郭佳,曹杜玲,朱武   

  1. 中南大学湘雅医院皮肤科，湖南长沙，410008
  • 出版日期:2021-08-15 发布日期:2021-07-21
  • 通讯作者: 朱武，E-mail: zhuwu70@hotmail.com

Recombinant human tumor necrosis factor receptor type II-IgG Fc fusion protein with glucocorticoid successfully treat Stevens-Johnson syndrome: a case report

LU Wenhua, GUO Jia, CAO Duling, ZHU Wu   

  1. Department of Dermatology, Xiangya Hospital of Central South University, Changsha 410008, China
  • Online:2021-08-15 Published:2021-07-21
  • Contact: ZHU Wu, E-mail: zhuwu70@hotmail.com

PDF (PC)

219

摘要： 患者，女，35岁。躯干四肢红斑、水疱8天。临床表现及组织病理检查符合重症多形红斑型药疹（Stevens-Johnson syndrome，SJS），重组人II型肿瘤坏死因子受体抗体融合蛋白单次联合糖皮质激素治疗后痊愈无复发。

关键词: 重症多形红斑型药疹, 重组人II型肿瘤坏死因子受体抗体融合蛋白, TNF-α抑制剂

Abstract: A 35-year-old female with erythema and blisters on trunk and limbs for 8 days. The clinical manifestations and the features of histological examination were consistent with drug-induced Stevens-Johnson syndrome (SJS). After one time injection with recombinant human tumor necrosis factor receptor type II-IgG Fc fusion protein and glucocorticoid, she recovered without recurrence.

Key words: Stevens-Johnson syndrome, recombinant human tumor necrosis factor receptor type II-IgG Fc fusion protein, TNF-α inhibitor